Context Therapeutics (CNTX) Short Interest Ratio & Short Volume → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free CNTX Stock Alerts $1.36 -0.05 (-3.55%) (As of 11:39 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Context Therapeutics Short Interest DataCurrent Short Volume11,200 sharesPrevious Short Volume17,000 sharesChange Vs. Previous Month-34.12%Dollar Volume Sold Short$15,456.00Short Interest Ratio / Days to Cover0.2Last Record DateMarch 31, 2024Float Size14,040,000 sharesShort Percent of Float0.08%Today's Trading Volume27,748 sharesAverage Trading Volume51,820 sharesToday's Volume Vs. Average54% Short Selling Context Therapeutics ? Sign up to receive the latest short interest report for Context Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCNTX Short Interest Over TimeCNTX Days to Cover Over TimeCNTX Percentage of Float Shorted Over Time Ad Tips4TradersUncover this 2024 Hidden GemExclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.[Click here to subscribe] and elevate your trading today. Context Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202411,200 shares $15,456.00 -34.1%0.1%0.2 $1.38 3/15/202417,000 shares $18,530.00 +57.4%0.1%0.3 $1.09 2/29/202410,800 shares $12,312.00 -60.0%0.1%0.2 $1.14 2/15/202427,000 shares $27,540.00 -3.2%0.2%0.6 $1.02 1/31/202427,900 shares $28,458.00 -14.9%0.2%0.7 $1.02 1/15/202432,800 shares $39,032.00 +70.8%0.2%0.8 $1.19 Get the Latest News and Ratings for CNTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/202319,200 shares $21,696.00 -37.9%0.1%0.4 $1.13 12/15/202330,900 shares $30,282.00 +37.3%0.2%0.7 $0.98 11/30/202322,500 shares $19,125.00 -37.2%0.2%0.6 $0.85 11/15/202335,800 shares $36,337.00 -28.7%0.3%1 $1.02 10/31/202350,200 shares $53,212.00 +11.8%0.4%1.4 $1.06 10/15/202344,900 shares $57,921.00 +14.5%0.3%1.2 $1.29 9/30/202339,200 shares $59,192.00 +184.1%0.3%1 $1.51 9/15/202313,800 shares $13,319.76 +97.1%0.1%0.3 $0.97 8/31/20237,000 shares $7,210.00 No Change0.1%0.1 $1.03 8/15/20237,000 shares $8,540.00 -25.5%0.1%0.1 $1.22 7/31/20239,400 shares $10,340.00 -86.9%0.1%0.1 $1.10 7/15/202371,600 shares $85,920.00 -52.2%0.5%0.5 $1.20 6/30/2023149,900 shares $239,840.00 +30.4%1.0%0.9 $1.60 6/15/2023115,000 shares $140,300.00 -54.6%0.8%0.7 $1.22 5/31/2023253,300 shares $220,371.00 +153.3%1.7%1.5 $0.87 5/15/2023100,000 shares $49,310.00 -15.6%0.7%1 $0.49 4/30/2023118,500 shares $68,860.35 +6.8%0.9%1 $0.58 4/15/2023111,000 shares $69,352.80 +19.5%0.8%0.1 $0.62 3/31/202392,900 shares $52,228.38 -54.6%0.7%0 $0.56 3/15/2023204,800 shares $141,619.20 +33.9%1.5%0.1 $0.69 2/28/2023152,900 shares $117,733.00 -27.2%1.1%0.1 $0.77 2/15/2023210,100 shares $175,475.52 -53.7%1.6%0.1 $0.84 1/31/2023453,800 shares $481,028.00 -25.1%3.3%0.2 $1.06 1/15/2023605,500 shares $443,831.50 +676.3%4.4%0.9 $0.73 12/30/202278,000 shares $50,832.60 -7.9%0.6%0.1 $0.65 12/15/202284,700 shares $55,902.00 -53.2%0.6%0.6 $0.66 11/30/2022181,100 shares $249,918.00 +11.2%1.3%0.9 $1.38 11/15/2022162,800 shares $195,360.00 -29.6%1.2%0.8 $1.20 10/31/2022231,300 shares $291,438.00 +616.1%1.7%0.8 $1.26 10/15/202232,300 shares $35,207.00 -74.3%0.2%0.1 $1.09 9/30/2022125,500 shares $139,305.00 +119.4%0.9%0.4 $1.11 9/15/202257,200 shares $92,664.00 -58.0%0.4%0.2 $1.62 8/31/2022136,300 shares $258,970.00 +48.6%1.0%0.4 $1.90 8/15/202291,700 shares $182,483.00 -26.2%0.7%0.2 $1.99One trade. One ticker. One week. (Ad)Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. CNTX Short Interest - Frequently Asked Questions What is Context Therapeutics' current short interest? Short interest is the volume of Context Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 11,200 shares of CNTX short. 0.08% of Context Therapeutics' shares are currently sold short. Learn More on Context Therapeutics' current short interest. What is a good short interest percentage for Context Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Context Therapeutics' floating shares are currently sold short. Is Context Therapeutics' short interest increasing or decreasing? Context Therapeutics saw a drop in short interest in March. As of March 31st, there was short interest totaling 11,200 shares, a drop of 34.1% from the previous total of 17,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Context Therapeutics' float size? Context Therapeutics currently has issued a total of 0 shares. Some of Context Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Context Therapeutics currently has a public float of 14,040,000 shares. How does Context Therapeutics' short interest compare to its competitors? 0.08% of Context Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Context Therapeutics: Grifols, S.A. (2.32%), LAVA Therapeutics (1.50%), Mainz Biomed (2.34%), NLS Pharmaceutics Ltd. (1.54%), Pharvaris (0.10%), American Oncology Network, Inc. (1.02%), Concord Medical Services Holdings Limited (0.06%), Aethlon Medical, Inc. (0.74%), Enveric Biosciences, Inc. (4.23%), Unicycive Therapeutics, Inc. (1.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Context Therapeutics stock? Short selling CNTX is an investing strategy that aims to generate trading profit from Context Therapeutics as its price is falling. CNTX shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Context Therapeutics? A short squeeze for Context Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTX, which in turn drives the price of the stock up even further. How often is Context Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: GRFS Short Squeeze LVTX Short Squeeze MYNZ Short Squeeze NLSP Short Squeeze PHVS Short Squeeze TLSA Short Squeeze ATNFW Short Squeeze ACONW Short Squeeze AIMDW Short Squeeze DRTSW Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNTX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingPrepare for a recession unlike any otherAmerican Hartford Gold GroupExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsGoldenCrest Metals